AMCP is partnering with industry leaders to host two Corporate Trainings at AMCP 2020:
- Health Care Actuaries: What are they and how do they influence payer decision making?
- Pre-Approval Information Exchange (PIE): Implementing pre-approval communication strategies
Health Care Actuaries: What are they and how do they influence payer decision making?
An AMCP and Optum Advisory Services Training Program.
Join leading managed care and health plan experts for an invaluable and interactive training program that introduces the role of a health plan actuary and illustrates the actuarial influences on payer decision making.
Pharmacy risk is big, changing and uncertain, creating both financial risk and opportunities across the pharmacy ecosystem. Life science companies continue to innovate novel drug therapies especially within the specialty drug space and payers rely on actuaries to understand and incorporate the impacts of these therapies into the price of the insurance product. With this level of unprecedented change, stakeholders must navigate the complex operational, regulatory, and fiscal pharmacy environment.
This invaluable and interactive AMCP Corporate Training program will introduce the role of a health plan actuary, familiarize the audience with how a health plan actuary models and prepares for market disruptions, and then offers a deep dive into Medicare market dynamics through the lens of the health plan actuary. Learn more.
Tuesday, April 21 | 11:00am-6:00pm
$1,995 (inclusive of meeting registration)
Cancellation Fee: $400
Registration cap: 60
Register Now!
Pre-Approval Information Exchange (PIE): Implementing pre-approval communication strategies
An AMCP and Xcenda Training Program.
It’s been nearly two years since the U.S. Food and Drug Administration (FDA) provided final guidance on preapproval information exchange (PIE). Since then, payors have received information from manufacturers about medical products that are not yet approved by the FDA for any use as well as unapproved uses of already approved medical products. This information may allow payors to plan and budget for future coverage and reimbursement decisions before FDA approval.
This AMCP Corporate Training will outline how to leverage PIE within FDA’s guidance, especially for oncology products and rare diseases given the disproportional number of these products in the biopharmaceutical pipeline. Learn more.
Tuesday, April 21 | 8:00am to 12:00pm
Price: $895 (Add-on, not inclusive of a meeting registration)
Cancellation Fee: $400
Registration cap: 60
(Breakfast included)
Register Now!